A long supported innovation for #NeonatalHealth gets to the field & what better place to start than an underserved tribal community?
CCAMP supported neonatal sepsis monitoring tech gets deployed in tribal majority Sargur, Karnataka in partnership with @SELCOFoundation@SpotSense
DYK that even when new #antibiotics are approved, they
rarely target priority #drugresistant bacteria and are only
registered for use in a small number of countries? Find out how you can support our life-saving work right here: https://t.co/cYgOfNXheo #ResistResistance
#COVID19 interventions in resource-limited settings need to be affordable, available, and adapted to the health care systems and the populations they are serving. #COVID19crc@TheLancet https://t.co/zlWydJXth7
@MoHFW_INDIA@ICMRDELHI Need your intervention to control prices for Rapid Kits. Rs. 200-300 kits are now costing Rs 1000 - pls look into this else the benefit of using Rapid Kits to quickly test millions of citizens at scale becomes economically impossible. @StartupsvsCovid
Just to re-up, diagnostic capacity is not a new issue. It's not just a COVID problem; it's a TB, antibiotic resistance, malaria, HIV, sepsis, cold problem https://t.co/zVt3lmPiFm @paimadhu
"If you look at the Coronavirus #COVIDー19 conversation now, containment without providing care doesn’t work well. If you're not concerned with treatment, this is a colonial recipe for mistrust."
-Paul Farmer Co-founder of Partners in Health, and Duke Trustee @DukeGHI@DukeU
Health tools developed in wealthy countries can take 𝙙𝙚𝙘𝙖𝙙𝙚𝙨 to reach the people who need them most.
By investing in home-grown innovation, we can accelerate and expand the reach of lifesaving breakthroughs 💉💊🔬. https://t.co/hrhQQezsCD
At the very onset of behavioural research for #AntibioticResistance stewardship we should perhaps curate stories of what hasn’t worked. Including the interventional methodology and failure nodes. This seems like a good step in that direction.
Last year @Wellcome_AMR had a go at a project to tackle overuse and misuse of #antibiotics in India and Kenya. It didn't work out the way we hoped...
Here are 5 things we learned – hope also useful to others using #BehaviouralInsights to create change 👇
https://t.co/zRX3Hnw35b
Dr. M. K. Bhan passed away a short while ago. A great pediatrician and humanist, foremost. A clinician scientist who pioneered a rotavirus vaccine, excellent science administrator, leader of complex missions in health and nutrition, a dear friend. Too sudden and too soon.
We are deeply saddened to learn the news that Dr. Peter Salama, epidemiologist and @WHO's Executive Director of the Division of Universal Health Coverage, has passed. Our thoughts are with his family and our friends and partners at WHO at this time.
Antibiotic resistance has become a serious threat to human health around the world. We caught up with #AMR#diagnostic innovators and clinicians about their thoughts on the impact of #AMR on healthcare and the people facing these issues in India. https://t.co/ZiepPwpA0P
Sepsis is a leading cause of death in children under 5 & threatens achievement of SDG3. A new Lancet report shows sepsis deaths twice as high as previously thought. #GARDP is working with partners to develop new & improved treatments for neonatal sepsis: https://t.co/ZGHFRTdyNE
Honoured to take over as President NNF of India 2020 from Dr V.P. Goswami, organisation with 8500 members. Aiming to set high academic standards for Gen Z ; providing #quality healthcare for newborns with partnership with @MoHFW_INDIA and neonatal nurses @iapindia@Nnfindia1